FOSTER CITY, Calif.--(BUSINESS WIRE)--Hepta, a biotechnology company using transformer-based AI to decode the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, ...
Hepta’s liquid biopsy-native AI model links coordinated methylation and gene expression changes to fibrosis progression, showing that liver biology can be measured non-invasively from blood Hepta, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback